M 253
Pill imprint M 253 has been identified as Acyclovir 400 MG.
Acyclovir is used in the treatment of herpes simplex; herpes simplex, suppression; herpes zoster; herpes simplex, mucocutaneous/immunocompetent host; varicella-zoster (and more), and belongs to the drug class purine nucleosides. There is no proven risk in humans during pregnancy.
Acyclovir 400 MG is not subject to the Controlled Substances Act.
See also related documents.
Acyclovir Images
- Imprint:
-
M 253
- Strength:
- 400 MG
- Color:
- White
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
magnesium stearate
microcrystalline cellulose
povidone
sodium lauryl sulfate
- Drug Class:
- Purine nucleosides
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0253
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0448 | UDL Laboratories Inc |
| 66267-0007 | Nucare Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More ACYCLOVIR resources
- Acyclovir
- Acyclovir (Wolters Kluwer)
- Acyclovir Capsules (Wolters Kluwer)
- Acyclovir Suspension (Wolters Kluwer)
- acyclovir (Cerner Multum)
- acyclovir injection (Cerner Multum)
- acyclovir Oral, Intravenous (Micromedex) - Includes Dosage Information
- Acyclovir (AHFS DI)
- Acyclovir Sodium (AHFS DI)
- Acyclovir Capules (FDA)
- Acyclovir IV Infusion (FDA)
- Acyclovir Injection (FDA)
- Acyclovir Oral Suspension (FDA)
- Acyclovir Tablets (FDA)
Search Again
